Unique identifier (udi) #: (b)(4).Device labeling addresses lymphoma: there were no reported events of lymphoma/alcl, for pts in the core study, in the labeling for silicone implants.Device labeling addresses seroma: "potential adverse events that may occur with silicone gel-filled breast implant surgery include: implant rupture, capsular contracture, reoperation, implant removal, pain, changes in nipple and breast sensation, infection, scarring, asymmetry, wrinkling, implant displacement/migration, implant palpability/visibility, breastfeeding complications, hematoma/seroma, implant extrusion, necrosis, delayed wound healing, breast tissue atrophy/chest wall deformity, calcium deposits, and lymphadenopathy".Device labeling addresses crease/folding of implant: "the following things may cause implants to rupture: damage by surgical instruments; stressing the implant during implantation and weakening it; folding or wrinkling of the implant shell".
|
Analysis of device is as follows: the implant weighed 394.26 grams.Gray particles were observed on the implant shell.One linear opening was observed on the radius of the implant shell.Creases were observed on the implant shell.One striated opening, 1.1 mm in length, was located on the posterior portion of the implant.
|